Komori
Changes in Officers4503Astellas Pharma Inc.Pharmaceuticals

Notice Regarding Changes in Officers

Following the annual general meeting of shareholders scheduled for 19 June 2026, the board structure will change from the current composition to one in which most incumbent directors are reappointed, while 2 outside directors and 1 outside director who is an Audit and Supervisory Committee member retire. Shigeki Takahara (高原 茂季) is scheduled to be appointed as a new outside director who is an Audit and Supervisory Committee member.

Worth reading
64In focus
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 27 April 2026

Incoming appointee

1 item
Scheduled Appointment Date19 June 2026 (to be formally decided at the annual general meeting of shareholders and the board meeting scheduled for the same day)
Shigeki Takahara (高原 茂季)
Previous positionAdviser, KANSAI PAINT CO.,LTD. (currently serving)
New positionOutside Director (Audit and Supervisory Committee Member)
生年月日 12 November 1958

Departing officer

1 item
Date of departure19 June 2026 (予定)
Koji Tanaka (田中 孝司), Eriko Sakurai (桜井 恵理子), Mika Nakayama (中山 美加)Stepping down
Former PositionKoji Tanaka (田中 孝司): Outside Director; Eriko Sakurai (桜井 恵理子): Outside Director; Mika Nakayama (中山 美加): Outside Director (Audit and Supervisory Committee Member)
Directors after the change11Number
Shareholders’ meeting approvalRequired. The matter is scheduled to be submitted to the 21st Annual General Meeting of Shareholders scheduled for 19 June 2026 (agenda item name: Not disclosed)
Who is moving to which position
ItemDetails
Resolution date27 April 2026
Scheduled Appointment Date19 June 2026 (to be formally decided at the annual general meeting of shareholders and the board meeting scheduled for the same day)
Date of departure19 June 2026 (予定)
Name of appointeeShigeki Takahara (高原 茂季)
Appointee's new positionOutside Director (Audit and Supervisory Committee Member)
Appointee's previous positionAdviser, KANSAI PAINT CO.,LTD. (currently serving)
Appointee's date of birth12 November 1958
Name of departing officerKoji Tanaka (田中 孝司), Eriko Sakurai (桜井 恵理子), Mika Nakayama (中山 美加)
Former position of departing officerKoji Tanaka (田中 孝司): Outside Director; Eriko Sakurai (桜井 恵理子): Outside Director; Mika Nakayama (中山 美加): Outside Director (Audit and Supervisory Committee Member)
Number of directors after the change11 (including 7 outside directors)
Subject to Approval by the General Meeting of ShareholdersRequired. The matter is scheduled to be submitted to the 21st Annual General Meeting of Shareholders scheduled for 19 June 2026 (agenda item name: Not disclosed)
Items this document does not state (10)
Year the appointee joined the CompanyNumber of shares held by the appointeeNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the changes in directors and officers is disclosed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Changes in Officers | Astellas Pharma Inc. (4503) timely disclosure | Komori